Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free SEATW Stock Alerts

Vivid Seats (SEATW) Financials

Vivid Seats logo
$0.06 0.00 (0.00%)
As of 06/12/2026
Compare
Annual Income Statements for Vivid Seats

Annual Income Statements for Vivid Seats

This table shows Vivid Seats' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 71 69 13
Consolidated Net Income / (Loss)		 71 113 14
Net Income / (Loss) Continuing Operations		 71 113 14
Total Pre-Tax Income 		69 71 23
Total Operating Income		 78 81 42
Total Gross Profit		 460 531 574
Total Revenue		 600 713 776
Operating Revenue		 600 713 776
Total Cost of Revenue		 141 182 202
Operating Cost of Revenue		 141 182 202
Total Operating Expenses		 382 449 532
Selling, General & Admin Expense		 128 159 202
Marketing Expense		 248 274 285
Depreciation Expense		 7.73 17 44
Other Operating Expenses / (Income)		 -2.07 -1.00 0.00
Total Other Income / (Expense), net		 -8.92 -10 -20
Interest Expense		 17 14 23
Other Income / (Expense), net		 8.23 3.11 3.67
Income Tax Expense		 -1.59 -42 8.42
Net Income / (Loss) Attributable to Noncontrolling Interest		 29 75 9.43
Basic Earnings per Share		 $0.36 $0.80 $0.07
Weighted Average Basic Shares Outstanding		 80.26M 92.68M 132.33M
Diluted Earnings per Share		 $0.36 $0.26 $0.06
Weighted Average Diluted Shares Outstanding		 198.74M 198.88M 209.14M
Weighted Average Basic & Diluted Shares Outstanding		 195.38M 210.18M 208.92M

Quarterly Income Statements for Vivid Seats

This table shows Vivid Seats' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 7.66 59 12 31 6.68 20 6.08 -1.06 5.30 3.12
Consolidated Net Income / (Loss)		 19 25 30 14 18 52 13 -0.44 11 -8.76
Net Income / (Loss) Continuing Operations		 19 33 30 38 16 29 11 -1.22 9.20 -4.42
Total Pre-Tax Income 		19 32 31 14 19 7.93 13 -0.64 13 -3.13
Total Operating Income		 22 25 34 18 20 10 21 7.88 11 2.90
Total Gross Profit		 119 225 123 123 138 147 141 150 136 147
Total Revenue		 157 296 161 165 188 198 191 198 187 200
Operating Revenue		 157 - 161 165 188 198 191 198 187 200
Total Cost of Revenue		 38 70 38 43 50 51 50 49 51 52
Operating Cost of Revenue		 38 - 38 43 50 51 50 49 51 52
Total Operating Expenses		 98 185 90 105 118 137 121 142 125 144
Selling, General & Admin Expense		 30 61 32 38 37 51 42 61 46 52
Marketing Expense		 66 - 55 65 77 77 68 70 68 79
Depreciation Expense		 2.16 2.46 2.60 2.70 3.30 8.58 10 11 11 13
Total Other Income / (Expense), net		 -2.84 -8.27 -2.95 -3.77 -1.51 -2.17 -7.66 -8.53 2.72 -6.04
Interest Expense		 2.90 7.60 3.28 2.77 2.54 4.91 5.08 5.32 6.30 6.47
Other Income / (Expense), net		 0.07 - 0.33 -1.00 1.04 2.74 -2.58 -3.20 9.02 0.43
Income Tax Expense		 0.12 -1.71 0.29 -24 2.60 -21 2.27 0.58 4.29 1.28
Net Income / (Loss) Attributable to Noncontrolling Interest		 11 3.17 18 31 6.68 19 4.67 -1.06 5.30 0.53
Basic Earnings per Share		 $0.09 $0.13 $0.16 $0.36 $0.07 $0.21 $0.05 ($0.01) $0.04 ($0.01)
Weighted Average Basic Shares Outstanding		 82.00M 80.26M 77.41M 85.27M 96.41M 92.68M 134.07M 131.80M 131.52M 132.33M
Diluted Earnings per Share		 $0.09 $0.13 $0.15 $0.20 $0.07 ($0.16) $0.04 ($0.01) $0.04 ($0.01)
Weighted Average Diluted Shares Outstanding		 82.02M 198.74M 195.82M 196.38M 96.86M 198.88M 210.91M 208.03M 131.95M 209.14M
Weighted Average Basic & Diluted Shares Outstanding		 199.50M 195.38M 195.88M 196.18M 196.41M 210.18M 207.65M 208.08M 207.75M 208.92M

Annual Cash Flow Statements for Vivid Seats

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -238 -120 112
Net Cash From Operating Activities		 14 147 54
Net Cash From Continuing Operating Activities		 13 147 54
Net Income / (Loss) Continuing Operations		 71 113 14
Consolidated Net Income / (Loss)		 71 113 14
Depreciation Expense		 7.73 17 44
Amortization Expense		 1.05 0.92 0.99
Non-Cash Adjustments To Reconcile Net Income		 18 25 52
Changes in Operating Assets and Liabilities, net		 -85 -9.10 -58
Net Cash From Investing Activities		 -15 -226 -27
Net Cash From Continuing Investing Activities		 -15 -226 -27
Purchase of Property, Plant & Equipment		 -3.56 -0.90 -4.23
Acquisitions		 -0.01 -207 -0.35
Other Investing Activities, net		 -12 -18 -22
Net Cash From Financing Activities		 -236 -43 86
Net Cash From Continuing Financing Activities		 -236 -43 86
Repayment of Debt		 -4.86 -0.28 -2.97
Repurchase of Common Equity		 -32 -20 -23
Payment of Dividends		 -5.25 -14 -10
Issuance of Debt		 275 0.00 0.00
Other Financing Activities, net		 -469 -8.76 122
Effect of Exchange Rate Changes		 0.00 1.90 -1.05
Cash Interest Paid		 15 19 19
Cash Income Taxes Paid		 0.00 4.02 5.47

Quarterly Cash Flow Statements for Vivid Seats

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -14 -22 52 2.88 -61 -114 31 81 -32 32
Net Cash From Operating Activities		 -0.02 13 65 18 32 33 39 -14 -19 48
Net Cash From Continuing Operating Activities		 0.00 11 65 -1.18 28 56 41 -13 -18 43
Net Income / (Loss) Continuing Operations		 19 25 30 14 18 51 13 -0.44 11 -8.76
Consolidated Net Income / (Loss)		 19 25 30 14 18 51 13 -0.44 11 -8.76
Depreciation Expense		 2.16 2.46 2.60 8.01 -2.00 8.58 10 11 11 13
Amortization Expense		 0.24 0.23 0.23 0.23 0.24 0.24 0.24 0.22 0.27 0.27
Non-Cash Adjustments To Reconcile Net Income		 5.49 4.35 5.36 -16 31 4.66 11 21 2.08 18
Changes in Operating Assets and Liabilities, net		 -27 -21 27 -7.10 -20 -9.06 6.26 -44 -41 21
Net Cash From Investing Activities		 -4.96 -3.53 -2.61 -2.98 -65 -155 -5.29 -5.26 -7.29 -8.90
Net Cash From Continuing Investing Activities		 -4.96 -3.53 -2.61 2.00 -70 -155 -5.29 -5.26 -7.29 -8.90
Purchase of Property, Plant & Equipment		 -1.34 -0.83 -0.22 -0.39 -0.18 -0.11 -0.09 -0.29 -0.39 -3.46
Acquisitions		 - - - - - -151 - - - -0.35
Other Investing Activities, net		 -3.62 -2.70 -2.39 - - -3.57 -5.20 -4.98 -6.90 -5.10
Net Cash From Financing Activities		 -8.66 -32 -11 -12 -4.19 -17 -4.61 99 -6.84 -1.80
Net Cash From Continuing Financing Activities		 -8.66 -32 -11 1.81 -18 -17 -4.61 99 -6.84 -1.80
Repurchase of Common Equity		 -3.05 -29 -7.61 - - -12 -3.11 -17 -2.93 0.02
Payment of Dividends		 -5.61 1.05 - - - -3.29 - - -2.84 -0.76
Issuance of Debt		 - - - - - - - - - -126
Other Financing Activities, net		 - -3.17 -3.19 1.81 -6.69 -0.69 -1.23 -0.10 -1.07 124
Cash Interest Paid		 3.60 4.91 1.94 5.32 5.99 6.08 6.07 10 0.62 2.77
Cash Income Taxes Paid		 - - 0.00 0.40 - 3.62 0.62 2.66 1.86 0.33

Annual Balance Sheets for Vivid Seats

This table presents Vivid Seats' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 1,151 1,550 1,636
Total Current Assets		 332 246 345
Cash & Equivalents		 252 125 243
Restricted Cash		 0.75 6.95 1.17
Accounts Receivable		 37 58 48
Inventories, net		 13 21 20
Prepaid Expenses		 30 34 33
Plant, Property, & Equipment, net		 10 10 13
Total Noncurrent Assets		 809 1,294 1,278
Goodwill		 715 947 943
Intangible Assets		 82 241 233
Noncurrent Deferred & Refundable Income Taxes		 0.00 86 78
Other Noncurrent Operating Assets		 12 20 24
Total Liabilities & Shareholders' Equity		 1,151 1,550 1,636
Total Liabilities		 671 963 1,022
Total Current Liabilities		 378 488 426
Short-Term Debt		 2.75 3.93 3.95
Accounts Payable		 161 258 233
Accrued Expenses		 182 192 165
Current Deferred Revenue		 32 35 24
Total Noncurrent Liabilities		 293 476 596
Long-Term Debt		 280 281 404
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 166 156
Other Noncurrent Operating Liabilities		 13 29 37
Commitments & Contingencies		 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 863 482 353
Total Equity & Noncontrolling Interests		 -383 105 261
Total Preferred & Common Equity		 -383 105 261
Total Common Equity		 -383 105 261
Common Stock		 664 1,096 1,268
Retained Earnings		 -1,014 -940 -930
Treasury Stock		 -32 -53 -76
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.75 -0.88

Quarterly Balance Sheets for Vivid Seats

This table presents Vivid Seats' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 1,181 1,228 1,325 1,385 1,589 1,655 1,611
Total Current Assets		 364 408 428 406 297 371 326
Cash & Equivalents		 274 303 306 269 154 234 202
Restricted Cash		 0.51 0.68 0.67 1.06 6.85 6.14 6.19
Accounts Receivable		 40 47 46 65 70 69 65
Inventories, net		 14 24 28 22 30 30 22
Prepaid Expenses		 35 33 47 49 37 32 30
Plant, Property, & Equipment, net		 8.84 10 10 10 9.83 9.66 9.59
Total Noncurrent Assets		 808 809 887 969 1,283 1,274 1,275
Goodwill		 715 715 715 760 944 942 947
Intangible Assets		 82 82 82 114 234 227 225
Noncurrent Deferred & Refundable Income Taxes		 - - 79 77 85 85 81
Other Noncurrent Operating Assets		 11 12 9.97 18 20 21 22
Total Liabilities & Shareholders' Equity		 1,181 1,228 1,325 1,385 1,589 1,655 1,611
Total Liabilities		 701 723 828 865 993 1,061 999
Total Current Liabilities		 405 431 429 454 525 470 413
Short-Term Debt		 2.75 2.75 2.75 3.31 3.58 3.95 3.95
Accounts Payable		 165 218 204 219 307 267 224
Accrued Expenses		 204 184 192 197 181 169 160
Current Deferred Revenue		 34 26 30 34 33 30 25
Total Noncurrent Liabilities		 295 292 399 411 468 591 586
Long-Term Debt		 279 279 279 282 280 403 402
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 99 99 160 162 162
Other Noncurrent Operating Liabilities		 16 13 21 30 28 26 23
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 905 902 790 641 457 438 282
Total Equity & Noncontrolling Interests		 -425 -397 -293 -120 140 156 329
Total Preferred & Common Equity		 -425 -397 -293 -120 140 156 329
Total Common Equity		 -425 -397 -293 -120 140 156 329
Common Stock		 602 645 718 885 1,130 1,164 1,334
Retained Earnings		 -1,024 -1,002 -971 -965 -934 -935 -929
Treasury Stock		 -3.05 -40 -40 -40 -57 -73 -76
Accumulated Other Comprehensive Income / (Loss)		 - - - -0.17 -0.38 -1.22 0.77

Annual Metrics And Ratios for Vivid Seats

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 35.49% 18.76% 8.80%
EBITDA Growth		 16.03% 7.81% -11.15%
EBIT Growth		 14.83% -2.18% -45.66%
NOPAT Growth		 49.07% 62.35% -79.51%
Net Income Growth		 470.01% 59.85% -87.36%
EPS Growth		 1,000.00% -27.78% -76.92%
Operating Cash Flow Growth		 -91.82% 924.83% -63.40%
Free Cash Flow Firm Growth		 -116.90% -183.73% 88.54%
Invested Capital Growth		 29.01% 44.80% 5.13%
Revenue Q/Q Growth		 21.88% -12.03% 0.20%
EBITDA Q/Q Growth		 -10.40% -5.03% -5.66%
EBIT Q/Q Growth		 -12.70% -12.03% -17.16%
NOPAT Q/Q Growth		 -18.31% 8.41% -61.54%
Net Income Q/Q Growth		 52.93% 30.94% -80.83%
EPS Q/Q Growth		 89.47% -52.73% 166.67%
Operating Cash Flow Q/Q Growth		 137.75% 15.66% 38.02%
Free Cash Flow Firm Q/Q Growth		 0.00% -238.80% 94.43%
Invested Capital Q/Q Growth		 4.72% 37.94% -3.89%
Profitability Metrics		 - - -
Gross Margin		 76.59% 74.44% 73.97%
EBITDA Margin		 15.85% 14.39% 11.75%
Operating Margin		 13.01% 11.41% 5.44%
EBIT Margin		 14.38% 11.85% 5.92%
Profit (Net Income) Margin		 11.79% 15.87% 1.84%
Tax Burden Percent		 102.30% 159.48% 62.95%
Interest Burden Percent		 80.14% 84.01% 49.51%
Effective Tax Rate		 -2.30% -59.48% 37.05%
Return on Invested Capital (ROIC)		 17.64% 20.76% 3.51%
ROIC Less NNEP Spread (ROIC-NNEP)		 -3,068.96% 2.60% -4.28%
Return on Net Nonoperating Assets (RNNOA)		 -2.00% 0.45% -1.12%
Return on Equity (ROE)		 15.63% 21.21% 2.38%
Cash Return on Invested Capital (CROIC)		 -7.70% -15.84% -1.50%
Operating Return on Assets (OROA)		 6.74% 6.25% 2.88%
Return on Assets (ROA)		 5.53% 8.38% 0.90%
Return on Common Equity (ROCE)		 -21.47% -5.52% 0.73%
Return on Equity Simple (ROE_SIMPLE)		 -18.49% 107.74% 5.48%
Net Operating Profit after Tax (NOPAT)		 80 130 27
NOPAT Margin		 13.31% 18.20% 3.43%
Net Nonoperating Expense Percent (NNEP)		 3,086.60% 18.16% 7.79%
Return On Investment Capital (ROIC_SIMPLE)		 -79.79% 33.28% 3.97%
Cost of Revenue to Revenue		 23.41% 25.56% 26.03%
SG&A Expenses to Revenue		 21.26% 22.32% 26.06%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 63.58% 63.03% 68.53%
Earnings before Interest and Taxes (EBIT)		 86 84 46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 95 103 91
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 11.82 3.68
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.43 1.74 1.24
Price to Earnings (P/E)		 20.57 17.88 71.64
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 4.86% 5.59% 1.40%
Enterprise Value to Invested Capital (EV/IC)		 4.60 2.54 1.90
Enterprise Value to Revenue (EV/Rev)		 3.91 2.63 1.91
Enterprise Value to EBITDA (EV/EBITDA)		 24.70 18.29 16.22
Enterprise Value to EBIT (EV/EBIT)		 27.21 22.21 32.20
Enterprise Value to NOPAT (EV/NOPAT)		 29.41 14.46 55.59
Enterprise Value to Operating Cash Flow (EV/OCF)		 163.44 12.73 27.41
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.59 0.49 0.66
Long-Term Debt to Equity		 0.58 0.48 0.66
Financial Leverage		 0.00 0.17 0.26
Leverage Ratio		 2.83 2.53 2.65
Compound Leverage Factor		 2.27 2.13 1.31
Debt to Total Capital		 37.05% 32.68% 39.90%
Short-Term Debt to Total Capital		 0.36% 0.45% 0.39%
Long-Term Debt to Total Capital		 36.69% 32.22% 39.51%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 113.13% 55.27% 34.54%
Common Equity to Total Capital		 -50.18% 12.05% 25.56%
Debt to EBITDA		 2.97 2.78 4.47
Net Debt to EBITDA		 0.32 1.49 1.79
Long-Term Debt to EBITDA		 2.94 2.74 4.43
Debt to NOPAT		 3.54 2.20 15.34
Net Debt to NOPAT		 0.38 1.17 6.13
Long-Term Debt to NOPAT		 3.50 2.17 15.19
Altman Z-Score		 0.79 0.38 0.28
Noncontrolling Interest Sharing Ratio		 237.32% 126.03% 69.51%
Liquidity Ratios		 - - -
Current Ratio		 0.88 0.50 0.81
Quick Ratio		 0.76 0.38 0.69
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -35 -99 -11
Operating Cash Flow to CapEx		 404.02% 16,460.34% 1,275.66%
Free Cash Flow to Firm to Interest Expense		 -2.03 -7.33 -0.49
Operating Cash Flow to Interest Expense		 0.84 10.91 2.33
Operating Cash Flow Less CapEx to Interest Expense		 0.63 10.84 2.14
Efficiency Ratios		 - - -
Asset Turnover		 0.47 0.53 0.49
Accounts Receivable Turnover		 16.52 15.01 14.52
Inventory Turnover		 11.44 10.78 9.94
Fixed Asset Turnover		 104.28 69.26 68.26
Accounts Payable Turnover		 0.80 0.87 0.82
Days Sales Outstanding (DSO)		 22.09 24.32 25.13
Days Inventory Outstanding (DIO)		 31.89 33.86 36.72
Days Payable Outstanding (DPO)		 457.86 419.55 443.47
Cash Conversion Cycle (CCC)		 -403.88 -361.37 -381.61
Capital & Investment Metrics		 - - -
Invested Capital		 510 739 777
Invested Capital Turnover		 1.33 1.14 1.02
Increase / (Decrease) in Invested Capital		 115 229 38
Enterprise Value (EV)		 2,349 1,875 1,478
Market Capitalization		 1,456 1,241 962
Book Value per Share		 ($1.92) $0.53 $1.26
Tangible Book Value per Share		 ($5.91) ($5.52) ($4.41)
Total Capital		 763 872 1,022
Total Debt		 283 285 408
Total Long-Term Debt		 280 281 404
Net Debt		 30 152 163
Capital Expenditures (CapEx)		 3.56 0.90 4.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -296 -370 -321
Debt-free Net Working Capital (DFNWC)		 -44 -238 -77
Net Working Capital (NWC)		 -46 -242 -81
Net Nonoperating Expense (NNE)		 9.12 17 12
Net Nonoperating Obligations (NNO)		 30 152 163
Total Depreciation and Amortization (D&A)		 8.78 18 45
Debt-free, Cash-free Net Working Capital to Revenue		 -49.32% -51.94% -41.43%
Debt-free Net Working Capital to Revenue		 -7.29% -33.36% -9.88%
Net Working Capital to Revenue		 -7.75% -33.91% -10.39%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.36 $0.80 $0.07
Adjusted Weighted Average Basic Shares Outstanding		 80.26M 92.68M 132.33M
Adjusted Diluted Earnings per Share		 $0.36 $0.26 $0.06
Adjusted Weighted Average Diluted Shares Outstanding		 198.74M 198.88M 209.14M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 195.38M 210.18M 208.92M
Normalized Net Operating Profit after Tax (NOPAT)		 55 57 27
Normalized NOPAT Margin		 9.11% 7.99% 3.43%
Pre Tax Income Margin		 11.53% 9.95% 2.93%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 5.04 6.25 1.98
NOPAT to Interest Expense		 4.66 9.61 1.15
EBIT Less CapEx to Interest Expense		 4.83 6.19 1.80
NOPAT Less CapEx to Interest Expense		 4.45 9.54 0.96
Payout Ratios		 - - -
Dividend Payout Ratio		 7.41% 12.64% 70.02%
Augmented Payout Ratio		 53.32% 30.40% 230.71%

Quarterly Metrics And Ratios for Vivid Seats

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 12.38% 57.32% 0.00% 11.97% 19.97% -32.95% 18.50% 19.92% -0.81% 0.76%
EBITDA Growth		 37.14% -41.23% 137.53% -13.52% -19.77% -21.13% -21.41% -38.02% 58.42% -25.24%
EBIT Growth		 40.68% -45.65% 146.63% -37.92% -2.80% -48.14% -46.53% -71.83% -6.48% -74.05%
NOPAT Growth		 99.12% 11.05% 245.66% 172.05% -19.71% 39.15% -48.58% -88.69% -57.60% -94.41%
Net Income Growth		 1,115.76% 7,560.49% 864.69% -43.28% -5.80% 107.70% -57.49% -103.20% -39.85% -116.99%
EPS Growth		 0.00% 425.00% 650.00% 66.67% -22.22% -223.08% -73.33% -105.00% -42.86% 93.75%
Operating Cash Flow Growth		 -100.05% 132.90% 176.67% 179.35% 186,664.71% 153.61% -39.85% -178.63% -160.61% 45.10%
Free Cash Flow Firm Growth		 97.28% 0.00% 85.97% 105.70% -158.02% -116.92% -304.40% -1,256.82% -754.61% 81.34%
Invested Capital Growth		 7.40% 29.01% 22.09% 5.43% 9.92% 44.80% 48.89% 61.19% 50.89% 5.13%
Revenue Q/Q Growth		 6.18% 88.60% -45.54% 2.68% 13.76% 5.41% -3.76% 3.91% -5.91% 7.08%
EBITDA Q/Q Growth		 -15.88% 13.59% 33.54% -32.23% -21.96% 11.65% 33.07% -46.55% 99.49% -47.31%
EBIT Q/Q Growth		 -18.66% 13.74% 36.68% -50.90% 27.35% -39.31% 40.91% -74.13% 322.78% -83.16%
NOPAT Q/Q Growth		 20.29% 21.01% 27.22% 46.91% -64.50% 109.72% -52.99% -67.68% 33.06% -72.33%
Net Income Q/Q Growth		 -22.02% 32.30% 21.97% -54.92% 29.50% 191.71% -75.03% -103.40% 2,532.49% -182.42%
EPS Q/Q Growth		 -25.00% 44.44% 15.38% 33.33% -65.00% -328.57% 144.44% -125.00% 500.00% -125.00%
Operating Cash Flow Q/Q Growth		 99.92% 76,488.24% 401.39% -73.03% 80.63% 3.84% 18.92% -135.25% -39.24% 348.58%
Free Cash Flow Firm Q/Q Growth		 97.20% -636.93% 38.98% 145.22% -226.88% -519.54% -13.77% -29.35% 6.26% 86.47%
Invested Capital Q/Q Growth		 8.97% 4.72% -5.46% -2.27% 13.61% 37.94% -2.79% 5.81% 6.35% -3.89%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 76.01% 76.17% 76.56% 74.23% 73.18% 74.11% 74.02% 75.41% 72.65% 73.74%
EBITDA Margin		 15.41% 9.28% 22.76% 15.02% 10.31% 10.92% 15.10% 7.76% 16.46% 8.10%
Operating Margin		 13.84% 8.37% 20.81% 10.65% 10.69% 5.09% 10.83% 3.97% 5.77% 1.45%
EBIT Margin		 13.88% 8.37% 21.01% 10.05% 11.25% 6.47% 9.48% 2.36% 10.60% 1.67%
Profit (Net Income) Margin		 11.96% 8.39% 18.80% 8.25% 9.39% 26.00% 6.74% -0.22% 5.70% -4.38%
Tax Burden Percent		 99.45% 78.57% 99.07% 98.59% 94.94% 649.99% 98.92% 67.86% 78.82% 279.55%
Interest Burden Percent		 86.67% 127.60% 90.31% 83.31% 87.98% 61.77% 71.91% -13.76% 68.16% -94.06%
Effective Tax Rate		 0.63% -5.41% 0.93% -176.90% 13.94% -259.66% 17.44% 0.00% 31.81% 0.00%
Return on Invested Capital (ROIC)		 14.39% 11.69% 35.75% 50.00% 14.58% 20.89% 11.06% 3.50% 4.53% 1.04%
ROIC Less NNEP Spread (ROIC-NNEP)		 13.31% -419.96% 45.70% 248.25% 17.71% 37.58% 2.69% -4.96% 7.63% -5.80%
Return on Net Nonoperating Assets (RNNOA)		 16.44% -0.27% -2.87% -9.22% 0.40% 6.43% 0.25% -0.64% 1.43% -1.52%
Return on Equity (ROE)		 30.83% 11.42% 32.88% 40.78% 14.98% 27.33% 11.31% 2.86% 5.96% -0.48%
Cash Return on Invested Capital (CROIC)		 0.00% -7.70% 2.69% 21.72% 13.93% -15.84% -19.29% -33.60% -30.29% -1.50%
Operating Return on Assets (OROA)		 5.27% 3.93% 12.79% 6.14% 7.10% 3.42% 5.00% 1.23% 5.48% 0.81%
Return on Assets (ROA)		 4.54% 3.94% 11.44% 5.05% 5.93% 13.72% 3.56% -0.11% 2.94% -2.13%
Return on Common Equity (ROCE)		 -53.32% -15.68% -44.67% -30.72% -8.17% -7.11% -2.65% -0.36% 1.10% -0.15%
Return on Equity Simple (ROE_SIMPLE)		 -10.88% 0.00% -24.65% -29.83% -71.84% 0.00% 68.61% 52.41% 22.65% 0.00%
Net Operating Profit after Tax (NOPAT)		 22 26 33 49 17 36 17 5.52 7.34 2.03
NOPAT Margin		 13.75% 8.82% 20.61% 29.49% 9.20% 18.31% 8.94% 2.78% 3.93% 1.02%
Net Nonoperating Expense Percent (NNEP)		 1.08% 431.65% -9.95% -198.25% -3.13% -16.69% 8.37% 8.46% -3.10% 6.85%
Return On Investment Capital (ROIC_SIMPLE)		 - -26.06% - - - 9.32% - - - 0.30%
Cost of Revenue to Revenue		 23.99% 23.83% 23.44% 25.77% 26.82% 25.89% 25.98% 24.59% 27.35% 26.26%
SG&A Expenses to Revenue		 19.28% 20.68% 20.11% 23.16% 19.79% 25.80% 22.20% 30.79% 24.82% 26.22%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 62.17% 62.70% 55.75% 63.58% 62.48% 69.02% 63.19% 71.44% 66.88% 72.28%
Earnings before Interest and Taxes (EBIT)		 22 25 34 17 21 13 18 4.68 20 3.33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 24 27 37 25 19 22 29 15 31 16
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 11.82 9.02 7.66 2.34 3.68
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.11 2.43 1.96 1.99 1.55 1.74 1.70 1.54 0.99 1.24
Price to Earnings (P/E)		 34.00 20.57 16.88 14.19 11.62 17.88 19.88 37.85 25.53 71.64
Dividend Yield		 3.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.94% 4.86% 5.92% 7.05% 8.60% 5.59% 5.03% 2.64% 3.92% 1.40%
Enterprise Value to Invested Capital (EV/IC)		 5.02 4.60 4.91 4.91 3.58 2.54 2.56 2.37 1.54 1.90
Enterprise Value to Revenue (EV/Rev)		 4.97 3.91 3.11 2.97 2.36 2.63 2.47 2.32 1.61 1.91
Enterprise Value to EBITDA (EV/EBITDA)		 23.05 24.70 21.99 20.37 17.74 18.29 19.41 21.10 12.93 16.22
Enterprise Value to EBIT (EV/EBIT)		 24.74 27.21 24.22 23.74 19.95 22.21 26.75 31.68 22.54 32.20
Enterprise Value to NOPAT (EV/NOPAT)		 25.02 29.41 23.92 18.66 16.01 14.46 15.30 22.02 18.07 55.59
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 163.44 42.37 24.22 15.04 12.73 15.14 19.98 31.97 27.41
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 200.96 23.21 26.87 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.59 0.59 0.56 0.57 0.55 0.49 0.48 0.68 0.66 0.66
Long-Term Debt to Equity		 0.58 0.58 0.55 0.56 0.54 0.48 0.47 0.68 0.66 0.66
Financial Leverage		 1.23 0.00 -0.06 -0.04 0.02 0.17 0.09 0.13 0.19 0.26
Leverage Ratio		 6.16 2.83 2.67 2.67 2.56 2.53 2.56 2.73 2.65 2.65
Compound Leverage Factor		 5.34 3.61 2.41 2.22 2.26 1.56 1.84 -0.38 1.80 -2.50
Debt to Total Capital		 37.00% 37.05% 35.85% 36.15% 35.39% 32.68% 32.21% 40.63% 39.87% 39.90%
Short-Term Debt to Total Capital		 0.36% 0.36% 0.35% 0.35% 0.41% 0.45% 0.41% 0.39% 0.39% 0.39%
Long-Term Debt to Total Capital		 36.64% 36.69% 35.50% 35.80% 34.98% 32.22% 31.80% 40.23% 39.48% 39.51%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 118.84% 113.13% 114.66% 101.53% 79.54% 55.27% 51.92% 43.80% 27.73% 34.54%
Common Equity to Total Capital		 -55.85% -50.18% -50.51% -37.68% -14.93% 12.05% 15.87% 15.57% 32.39% 25.56%
Debt to EBITDA		 2.66 2.97 2.62 2.47 2.64 2.78 2.99 4.77 4.20 4.47
Net Debt to EBITDA		 0.07 0.32 -0.20 -0.22 0.14 1.49 1.29 1.95 2.04 1.79
Long-Term Debt to EBITDA		 2.63 2.94 2.59 2.45 2.61 2.74 2.95 4.72 4.16 4.43
Debt to NOPAT		 2.88 3.54 2.85 2.27 2.38 2.20 2.36 4.98 5.87 15.34
Net Debt to NOPAT		 0.08 0.38 -0.22 -0.21 0.13 1.17 1.02 2.03 2.85 6.13
Long-Term Debt to NOPAT		 2.85 3.50 2.82 2.25 2.36 2.17 2.33 4.93 5.81 15.19
Altman Z-Score		 0.54 0.61 0.78 0.73 0.49 0.22 0.27 0.29 0.11 0.19
Noncontrolling Interest Sharing Ratio		 272.97% 237.32% 235.86% 175.33% 154.55% 126.03% 123.41% 112.60% 81.52% 69.51%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.90 0.88 0.95 1.00 0.89 0.50 0.57 0.79 0.79 0.81
Quick Ratio		 0.78 0.76 0.81 0.82 0.73 0.38 0.43 0.65 0.65 0.69
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12 -89 -54 24 -31 -192 -219 -283 -265 -36
Operating Cash Flow to CapEx		 -1.27% 1,562.70% 30,284.19% 4,490.79% 17,718.44% 29,940.00% 42,570.65% -4,827.27% -4,941.90% 1,381.13%
Free Cash Flow to Firm to Interest Expense		 -4.15 -11.67 -16.50 8.83 -12.20 -39.19 -43.06 -53.17 -42.12 -5.55
Operating Cash Flow to Interest Expense		 -0.01 1.71 19.85 6.33 12.47 6.71 7.71 -2.59 -3.05 7.39
Operating Cash Flow Less CapEx to Interest Expense		 -0.47 1.60 19.79 6.19 12.40 6.69 7.69 -2.65 -3.11 6.86
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.38 0.47 0.61 0.61 0.63 0.53 0.53 0.52 0.52 0.49
Accounts Receivable Turnover		 10.42 16.52 15.15 17.18 15.39 15.01 12.78 13.50 11.90 14.52
Inventory Turnover		 6.80 11.44 8.48 7.66 11.29 10.78 7.23 6.87 9.17 9.94
Fixed Asset Turnover		 103.61 104.28 126.75 114.15 84.93 69.26 73.75 77.49 78.08 68.26
Accounts Payable Turnover		 0.57 0.80 0.78 0.95 1.05 0.87 0.74 0.85 0.91 0.82
Days Sales Outstanding (DSO)		 35.03 22.09 24.09 21.24 23.72 24.32 28.55 27.04 30.68 25.13
Days Inventory Outstanding (DIO)		 53.66 31.89 43.05 47.66 32.32 33.86 50.48 53.12 39.81 36.72
Days Payable Outstanding (DPO)		 638.17 457.86 465.22 383.15 348.55 419.55 494.37 429.20 403.19 443.47
Cash Conversion Cycle (CCC)		 -549.48 -403.88 -398.08 -314.26 -292.51 -361.37 -415.34 -349.03 -332.69 -381.61
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 487 510 483 472 536 739 718 760 808 777
Invested Capital Turnover		 1.05 1.33 1.73 1.70 1.58 1.14 1.24 1.26 1.15 1.02
Increase / (Decrease) in Invested Capital		 34 115 87 24 48 229 236 289 273 38
Enterprise Value (EV)		 2,447 2,349 2,371 2,316 1,916 1,875 1,838 1,798 1,249 1,478
Market Capitalization		 1,534 1,456 1,491 1,551 1,260 1,241 1,259 1,194 770 962
Book Value per Share		 ($2.12) ($1.92) ($2.03) ($1.50) ($0.61) $0.53 $0.66 $0.75 $1.58 $1.26
Tangible Book Value per Share		 ($6.10) ($5.91) ($6.11) ($5.57) ($5.07) ($5.52) ($4.94) ($4.88) ($4.05) ($4.41)
Total Capital		 762 763 787 779 806 872 879 1,001 1,017 1,022
Total Debt		 282 283 282 281 285 285 283 407 405 408
Total Long-Term Debt		 279 280 279 279 282 281 280 403 402 404
Net Debt		 7.50 30 -22 -25 15 152 122 166 197 163
Capital Expenditures (CapEx)		 1.34 0.83 0.22 0.39 0.18 0.11 0.09 0.29 0.39 3.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -313 -296 -324 -305 -315 -370 -386 -335 -291 -321
Debt-free Net Working Capital (DFNWC)		 -38 -44 -20 1.47 -45 -238 -225 -95 -83 -77
Net Working Capital (NWC)		 -41 -46 -23 -1.28 -49 -242 -228 -99 -87 -81
Net Nonoperating Expense (NNE)		 2.80 1.28 2.93 35 -0.36 -15 4.20 5.95 -3.29 11
Net Nonoperating Obligations (NNO)		 7.50 30 -22 -25 15 152 122 166 197 163
Total Depreciation and Amortization (D&A)		 2.40 2.70 2.82 8.23 -1.77 8.81 11 11 11 13
Debt-free, Cash-free Net Working Capital to Revenue		 -63.53% -49.32% -42.53% -39.20% -38.88% -51.94% -51.92% -43.23% -37.63% -41.43%
Debt-free Net Working Capital to Revenue		 -7.82% -7.29% -2.60% 0.19% -5.59% -33.36% -30.26% -12.23% -10.70% -9.88%
Net Working Capital to Revenue		 -8.38% -7.75% -2.96% -0.16% -6.00% -33.91% -30.74% -12.74% -11.21% -10.39%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.09 $0.13 $0.16 $0.36 $0.00 $0.21 $0.05 ($0.01) $0.04 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding		 82.00M 80.26M 77.41M 85.27M 96.41M 92.68M 134.07M 131.80M 131.52M 132.33M
Adjusted Diluted Earnings per Share		 $0.09 $0.13 $0.15 $0.20 $0.00 ($0.16) $0.04 ($0.01) $0.04 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 82.02M 198.74M 195.82M 196.38M 0.00 198.88M 210.91M 208.03M 131.95M 209.14M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 199.50M 195.38M 195.88M 196.18M 196.41M 210.18M 207.65M 208.08M 207.75M 208.92M
Normalized Net Operating Profit after Tax (NOPAT)		 22 17 33 12 17 7.07 17 5.52 7.34 2.03
Normalized NOPAT Margin		 13.75% 5.86% 20.61% 7.46% 9.20% 3.56% 8.94% 2.78% 3.93% 1.02%
Pre Tax Income Margin		 12.03% 10.68% 18.97% 8.37% 9.89% 4.00% 6.82% -0.32% 7.23% -1.57%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 7.50 3.26 10.32 5.99 8.32 2.62 3.56 0.88 3.14 0.52
NOPAT to Interest Expense		 7.43 3.43 10.12 17.59 6.81 7.40 3.36 1.04 1.17 0.31
EBIT Less CapEx to Interest Expense		 7.04 3.15 10.25 5.85 8.25 2.59 3.54 0.83 3.08 -0.02
NOPAT Less CapEx to Interest Expense		 6.97 3.32 10.06 17.45 6.74 7.37 3.34 0.98 1.10 -0.22
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 613.60% 7.41% 0.00% 0.00% 11.54% 12.64% 0.00% 0.00% 16.81% 70.02%
Augmented Payout Ratio		 613.60% 53.32% 40.96% 45.84% 54.42% 30.40% 16.28% 39.86% 64.36% 230.71%

Financials Breakdown Chart

Key Financial Trends

Vivid Seats’ recent financial trend has been mixed, with revenue holding relatively steady but profitability and cash generation weakening versus prior periods. In 2024, the company still produced solid top-line results, but higher operating costs, significant interest expense, and weaker working-capital movements pushed earnings into loss territory in the latest quarter. The balance sheet also shows a highly leveraged structure with meaningful liabilities and a large redeemable noncontrolling interest balance.

  • Revenue remained resilient in 2024. Quarterly revenue stayed near the $190 million to $200 million range, with Q4 2024 revenue of $199.8 million versus $198.3 million in Q2 2024 and $186.6 million in Q3 2024.
  • Gross profit stayed strong. Q4 2024 gross profit was $147.3 million, showing the business still keeps a healthy spread between revenue and direct costs.
  • Operating cash flow was positive in Q4 2024. The company generated $47.8 million of operating cash flow in Q4 2024 and $31.7 million in net cash growth for the quarter.
  • Cash and equivalents increased sequentially in late 2024. Cash and equivalents rose to $202.3 million at Q3 2024 from $154.0 million at Q1 2024, helping liquidity.
  • Operating income improved sharply from earlier 2024 quarters. Q4 2024 operating income of $2.9 million was well above the small losses seen in some earlier quarters and reflected better operating leverage than Q2 2024.
  • Seasonality is clearly visible. Revenue and profits fluctuate by quarter, so one strong or weak quarter may not reflect the full-year trend.
  • Depreciation and amortization remain meaningful non-cash add-backs. These items help cash flow, but they also indicate a capital structure and asset base that require ongoing support.
  • Share count remains elevated. Weighted average diluted shares were more than 209 million in Q4 2024, which can limit per-share earnings growth.
  • Net income turned negative in Q4 2024. The company reported a consolidated net loss of $8.8 million and a loss attributable to common shareholders of $3.1 million.
  • Operating expenses remain very heavy. In Q4 2024, operating expenses totaled $144.4 million, nearly matching gross profit and leaving very little room for profitability.
  • Marketing spend is large and persistent. Marketing expense was $79.5 million in Q4 2024, a major drag on margins.
  • Interest expense is a significant burden. Q4 2024 interest expense was $6.5 million, and the company’s debt load makes financing costs an ongoing concern.
  • Cash flow from operations was weak in Q3 2024. Operating cash flow was negative $19.2 million in Q3 2024, showing working-capital volatility can quickly pressure liquidity.
  • The balance sheet is highly leveraged. As of Q3 2024, total liabilities were about $999.1 million, including $401.5 million of long-term debt and $282.0 million of redeemable noncontrolling interest.
  • Equity remains thin relative to liabilities. Total common equity was only $329.4 million in Q3 2024, down from $139.6 million in Q1 2024 and much lower than liabilities.
  • Working capital swings can be severe. Changes in operating assets and liabilities were a major headwind in several quarters, including a negative $41.4 million impact in Q3 2024.

Bottom line: Vivid Seats continues to generate sizable revenue and can produce healthy cash in stronger quarters, but the latest filings show a business with thin operating margins, high marketing and interest costs, and a leveraged balance sheet. For retail investors, the key questions are whether management can stabilize profitability and reduce leverage while keeping revenue growth intact.

06/15/26 08:02 AM ETAI Generated. May Contain Errors.

Vivid Seats Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Vivid Seats' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Vivid Seats' net income appears to be on a downward trend, with a most recent value of $14.30 million in 2024, falling from $70.78 million in 2022. The previous period was $113.14 million in 2023.

Vivid Seats' total operating income in 2024 was $42.23 million, based on the following breakdown:
  • Total Gross Profit: $573.73 million
  • Total Operating Expenses: $531.51 million

Over the last 2 years, Vivid Seats' total revenue changed from $600.27 million in 2022 to $775.59 million in 2024, a change of 29.2%.

Vivid Seats' total liabilities were at $1.02 billion at the end of 2024, a 6.1% increase from 2023, and a 52.3% increase since 2022.

In the past 2 years, Vivid Seats' cash and equivalents has ranged from $125.48 million in 2023 to $251.54 million in 2022, and is currently $243.48 million as of their latest financial filing in 2024.

Over the last 2 years, Vivid Seats' book value per share changed from -1.92 in 2022 to 1.26 in 2024, a change of -165.5%.


Related Companies

Financial statements for NASDAQ:SEATW last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel